About Amylin
Amylin Pharmaceuticals, Inc. — Founded in 1987
- Committed to improving the lives of people with diabetes
- Engaged in the discovery, development, and commercialization of innovative therapies for the treatment of metabolic diseases
Amylin: http://www.amylin.com/about/contact-us.php
BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program.
BYETTA is not insulin and should not be taken instead of insulin. BYETTA can be used with Lantus® (insulin glargine), which is a long-acting insulin, but should not be taken with short- and/or rapid-acting insulin. BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis.